NASDAQ: CRWV
CoreWeave
Technology · Services-Prepackaged Software
52-week range
$51.24$141.79
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$54.9B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | — |
| FY2025, ended Dec 31, 2025 | $37.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $54.9B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$7.59B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2023, ended Dec 31, 2023 | $229M |
| FY2024, ended Dec 31, 2024 | $1.92B |
| FY2025, ended Dec 31, 2025 | $5.13B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.59B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2023, ended Dec 31, 2023 | −$594M | −$1.11B |
| FY2024, ended Dec 31, 2024 | −$863M | −$5.95B |
| FY2025, ended Dec 31, 2025 | −$1.17B | −$7.25B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$1.93B | −$13.7B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$5.52B
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2023, ended Dec 31, 2023 | $217M |
| FY2024, ended Dec 31, 2024 | $1.36B |
| FY2025, ended Dec 31, 2025 | $3.13B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $5.52B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.—
Show tableHide table
| Period | Total debt |
|---|---|
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | $7.93B |
| FY2025, ended Dec 31, 2025 | $21.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 187% since 2023.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.552M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2023, ended Dec 31, 2023 | 192M |
| FY2024, ended Dec 31, 2024 | 480M |
| FY2025, ended Dec 31, 2025 | 526M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 552M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Net: $619M more issued than bought back
Show tableHide table
| Period | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|
| FY2023, ended Dec 31, 2023 | $15.0M | $15.0M | — |
| FY2024, ended Dec 31, 2024 | $31.0M | $0 | — |
| FY2025, ended Dec 31, 2025 | $630M | $0 | $1.01B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $619M | — | — |
Revenue (TTM)
$7.59B
+115% YoY
Net income (TTM)
−$1.93B
n/m YoY
Cash
$5.52B
+379% YoY
Total debt
—
—
Valuation
At current price- Market Cap
- $35.3B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.6×
- Price / Book
- 7.0×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $7.59B
- Revenue Growth YoY
- 115%
- Revenue CAGR 3Y
- —. Compound annual growth over the last 3 fiscal years
- Revenue CAGR 5Y
- —. Compound annual growth over the last 5 fiscal years
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 67.4%
- Operating Margin
- −3.0%
- Net Margin
- −25.4%
- FCF Margin
- −180%
- Return on Equity
- −50.2%
Earnings
Trailing 12 months- Net Income
- −$1.93B
- EPS (diluted)
- −$3.55
- EBITDA
- $3.76B
- Operating Income
- −$231M
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $5.52B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $77.1B
- Total Liabilities
- $72.0B
- Shareholders' Equity
- $5.02B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $6.91B
- Capital Expenditure
- $20.6B
- Free Cash Flow
- −$13.7B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- —. 5-year monthly returns vs. S&P 500 (SPY)
Every ratio is calculated from the company’s reported figures.
Strength
Revenue grew 115% over the last year, to $7.59B.
Watch
Lost $1.93B over the last 12 months.
Watch
Free cash flow was negative (−$13.7B) over the last year.
Watch
Share count is up 12.9% in a year, diluting holders.
Written by fixed rules from the reported figures, not by a person or an AI.
From the 10-Q for Q2 FY2026 (period ended Jun 30, 2026), filed Aug 12, 2026. View filings on SEC EDGAR